#USA #Houston #Nutex Health #financial report #NUTX

Overview of Nutex Health Inc.

Nutex Health Inc., listed on NASDAQ under the symbol NUTX, is an innovative, physician-led healthcare company operating a network of micro-hospitals and office departments across 11 states. These facilities are designed to deliver quality healthcare services while ensuring a streamlined patient experience. Established in 2011 and headquartered in Houston, Texas, the company continues to expand its footprint in the U.S. healthcare system.

Financial Reporting Update

On August 20, 2025, Nutex Health made significant announcements regarding its financial reporting, specifically mentioning the need to amend previously issued financial statements due to a reclassification of certain obligations associated with under construction and ramping hospitals. This adjustment, impacting the accounting classifications related to equity and liabilities, is expected to be non-cash in nature. The company emphasized that this reclassification will not affect key financial metrics such as revenue, gross profit, or EBITDA.

The revisions pertain to the company’s Quarterly Report on Form 10-Q for the period ending March 31, 2025, and its Annual Report on Form 10-K for the years ended December 31, 2024, and 2023. Nutex is committed to transparency and will file amended reports to ensure compliance with accounting standards, thus maintaining investor confidence.

Preliminary Financial Results

Nutex Health's preliminary findings for the quarters ending in June 2025 reflect an extraordinary growth trajectory:

• - Total Revenue: $244 million for Q2 2025, marking a 220.7% increase from Q2 2024’s $76.1 million.
• - Gross Profit: Reached $124.8 million, accounting for 51.1% of total revenue, as opposed to $22.6 million (or 29.7%) for the previous year.
• - Patient Visits: Increased to 45,573 for Q2 2025, up by 10.6% year-over-year, with mature hospitals also showing an uptick in traffic.
• - Adjusted EBITDA: Impressive rise to $71.6 million compared to $6.8 million a year earlier, demonstrating operational efficiency and scalability.
• - Operating Cash Flow: Grew to $27.1 million, a notable increase from $13.3 million in Q2 2024.

For the first half of 2025, the company reported total revenues of $455.8 million, representing a significant rise of 217.5% from $143.5 million during the same period in 2024. The gross profit margin enhanced to 53.3%, emphasizing the effectiveness of Nutex Health’s operational strategies.

Shareholder Engagement and Future Directions

Nutex Health is proactive in maintaining communication with its shareholders. A conference call scheduled for August 25, 2025, will discuss these preliminary results and outline strategies moving forward. Participants are encouraged to dial in early to ensure attendance. The company insists on outlining its future growth plans amid the financial reporting updates and identifies strong avenues for profitability and expansion.

Compliance Notification from Nasdaq

Furthermore, Nutex received a notification from Nasdaq indicating non-compliance with listing rules due to delayed filings of the Quarterly Report on Form 10-Q. While there is a deadline for resolution, Nutex remains focused on fulfilling its compliance obligations swiftly and effectively.

Conclusion

In summary, Nutex Health Inc. is not only navigating changes in financial reporting but also achieving remarkable growth metrics within a challenging healthcare environment. Their commitment to transparency and operational excellence positions them favorably for continued success in the evolving healthcare landscape.